Kanpiduo

Indapamide and Candesartan Cilexetil, the active ingredient in Kanpiduo, is a combination antihypertensive presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients, employing complementary mechanisms to lower systolic and diastolic blood pressure and improve cardiovascular outcomes and reduce the risk of related complications through sustained blood pressure control.

GNH USA supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet European Union regulatory standards.

Kanpiduo is a combination antihypertensive used to treat conditions within the hypertension disease family.

Essential hypertension: lowers both systolic and diastolic blood pressure, helping achieve target levels. Secondary hypertension: provides effective blood pressure control when hypertension is caused by another underlying condition. Renal hypertension: assists in managing elevated blood pressure associated with renal disease.

Kanpiduo may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Increased urination: due to the diuretic component. - Electrolyte imbalance: such as low potassium or sodium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to hypotension. - Hyperkalemia: elevated potassium that can affect heart rhythm. - Angioedema: swelling of face, lips, tongue or throat requiring immediate medical attention.

When prescribing Kanpiduo, clinicians should observe several precautionary measures to ensure patient safety. - Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance before and during therapy. - Caution in hepatic impairment: adjust use if liver disease is present. - Avoid in severe hypotension: do not initiate if blood pressure is already low. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Kanpiduo can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - ACE inhibitors or other ARBs: increase risk of renal dysfunction and hyperkalemia. - Lithium: can raise lithium levels leading to toxicity. - NSAIDs: may reduce antihypertensive effect and impair renal function. - Concomitant use with other antihypertensives: may cause excessive blood pressure lowering.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance electrolyte disturbances. - Other diuretics: increase risk of dehydration. - Antidiabetic agents: blood glucose control may be affected. - CYP3A4 inhibitors: may modestly increase candesartan levels. - Antacids containing aluminum or magnesium: could affect absorption of indapamide.